[HTML][HTML] Outcomes with CD34-selected stem cell boost for poor graft function after allogeneic hematopoietic stem cell transplantation: a systematic review and meta …
M Shahzad, RS Siddiqui, I Anwar… - … and Cellular Therapy, 2021 - Elsevier
Poor graft function (PGF) is a life-threatening complication after allogeneic hematopoietic
stem cell transplantation (allo-HSCT) characterized by multilineage cytopenia in the …
stem cell transplantation (allo-HSCT) characterized by multilineage cytopenia in the …
[HTML][HTML] CD34+-selected stem cell boost without further conditioning for poor graft function after allogeneic stem cell transplantation in patients with hematological …
E Klyuchnikov, J El-Cheikh, A Sputtek… - Biology of blood and …, 2014 - Elsevier
We retrospectively analyzed outcomes of a CD34+-selected stem cell boost (SCB) without
prior conditioning in 32 patients (male/22; median age of 54 years; range, 20 to 69) with …
prior conditioning in 32 patients (male/22; median age of 54 years; range, 20 to 69) with …
Erythropoietin receptor signaling through STAT3 is required for glioma stem cell maintenance
Recombinant erythropoietin (EPO) is a growth factor used in the treatment of chemotherapy-
induced anemia, but recent studies suggest that EPO may accelerate cancer growth …
induced anemia, but recent studies suggest that EPO may accelerate cancer growth …
Патогенетическая коррекция анемии эритропоэзстимулирующими препаратами у больных лимфопролиферативными заболеваниями (обзор литературы)
НА Романенко, КМ Абдулкадыров - Онкогематология, 2011 - cyberleninka.ru
В статье представлен обзор литературы по патогенезу анемического синдрома (АС) у
больных с опухолевыми заболеваниями лимфатической системы. Показаны …
больных с опухолевыми заболеваниями лимфатической системы. Показаны …
[HTML][HTML] Fresh or cryopreserved CD34+-selected mobilized peripheral blood stem and progenitor cells for the treatment of poor graft function after allogeneic …
A Ghobadi, MA Fiala, G Ramsingh, F Gao… - Biology of Blood and …, 2017 - Elsevier
CD34+-selected stem cell boost (SCB) without conditioning has recently been utilized for
poor graft function (PGF) after allogeneic hematopoietic stem cell transplantation with …
poor graft function (PGF) after allogeneic hematopoietic stem cell transplantation with …
Erythropoietin therapy after allogeneic hematopoietic cell transplantation: a prospective, randomized trial
A Jaspers, F Baron, E Willems, L Seidel… - Blood, The Journal …, 2014 - ashpublications.org
We conducted a prospective randomized trial to assess hemoglobin (Hb) response to
recombinant human erythropoietin (rhEPO) therapy after hematopoietic cell transplantation …
recombinant human erythropoietin (rhEPO) therapy after hematopoietic cell transplantation …
[HTML][HTML] 纯化供者CD34+ 细胞输注治疗单倍型造血干细胞移植后移植物功能不良12 例临床分析
费新红， 贺俊宝， 程昊钰， 殷宇明， 张维婕… - Chinese Journal of …, 2018 - ncbi.nlm.nih.gov
纯化供者CD34+细胞输注治疗单倍型造血干细胞移植后移植物功能不良12例临床分析- PMC
Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI …
Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI …
[图书][B] Basics of Hematopoietic Stem Cell Transplant
SK Sharma - 2023 - Springer
HEMATOPOIETIC stem cell transplantation is a procedure used to treat benign and
malignant hematological and some nonhematological diseases. It took a lot of years and …
malignant hematological and some nonhematological diseases. It took a lot of years and …
Optimizing peripheral blood stem cells transplantation outcome through amend relapse and graft failure: a review of current literature
S Mohammadi, AH Norooznezhad… - … hematology & oncology, 2017 - Springer
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) has been considered as a
valuable approach in treatment of numerous malignant and none malignant hematologic …
valuable approach in treatment of numerous malignant and none malignant hematologic …
Factors associated with the avoidance of red blood cell transfusion after hematopoietic stem cell transplantation
N Kekre, G Christou, R Mallick, M Tokessy… - …, 2012 - Wiley Online Library
BACKGROUND: Red blood cell (RBC) transfusion is required frequently for most patients
after hematopoietic stem cell transplantation (HSCT). RBC transfusion, however, can be …
after hematopoietic stem cell transplantation (HSCT). RBC transfusion, however, can be …